News
UCSF at Dreamforce 2017: Precision Cancer Care and Public Health Tech
One of UC San Francisco’s groundbreaking cancer programs will be prominently featured at the 2017 Dreamforce conference through an interactive exposition and a talk by two researchers. UCSF at Dreamforce “Tech and Health: Connection as Cure” (live stream) Monday, Nov. 6 9:30 a.m.-10 a.m. Featuring
Survivors of Childhood Leukemia with Down Syndrome Have Unique Health Risks, Benefits
Doctors have long recognized that children with Down syndrome are significantly more susceptible to leukemia, and have believed that they also were at higher risk of treatment-related chronic conditions. Now, new research led by UCSF Benioff Children’s Hospital San Francisco, with data from the
Diverse Drug-Resistant Cancer Cells Share a Hidden Weakness
UC San Francisco researchers have discovered a gene vulnerability that could let oncologists wipe out drug-resistant cancers across many different cancer types. The findings, published in Nature on November 1, 2017, suggest a promising new approach to preventing cancer recurrence, if they can be
UCSF Launches Landmark $5B Fundraising Campaign to Solve the Most Complex Human Health Problems
UC San Francisco on Friday launched one of the largest fundraising efforts ever set by a U.S. university, a $5 billion campaign aimed at tackling the most complex biomedical questions of our day and working more broadly to improve the quality of people’s health over their lifetimes. Rising health
Public-Private Consortium Aims to Cut Preclinical Cancer Drug Discovery from Six Years to Just One
Lawrence Livermore National Laboratory, Frederick National Laboratory for Cancer Research, GSK, and University of California San Francisco will combine vast data stores, supercomputing, and scientific expertise to reinvent discovery process for cancer medicines SAN FRANCISCO, Oct 27, 2017 --
UCSF's Cryo-Electron Microscopy Advancements Bring Atomic-Level Life into Clearer View
UC San Francisco researchers recently captured exquisite images of a protein caught in the act of binding to a novel therapeutic drug with enough resolution to model how the individual atoms of the protein and drug lined up. Until recently, such a feat would have been considered impossible, but in
Big Data Shows How Cancer Interacts with Its Surroundings
By combining data from sources that at first seemed to be incompatible, UC San Francisco researchers have identified a molecular signature in tissue adjacent to tumors in eight of the most common cancers that suggests they are all using the same mechanism to remodel normal tissue and spread. The new